News & Events

Improvement of Doctoral Programs The Helmholtz Association has pledged to fund a Helmholtz graduate school and a Helmholtz research school at the MDC with a sum of 5.4 million euros for the coming six years.

The physician and developmental biologist Dr. Kai Martin Schmidt-Ott, formerly of Columbia University in New York, will establish and head an Emmy Noether Junior Research Group at the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany.

In Dresden he will head a research group on “Genomics of Regeneration”, whose aim is to explore complex processes such as the new formation of nerve cells and their development...

Dr. Oliver Smithies from the University of North Carolina at Chapel Hill, USA, has received the Commemorative Medal of the E.K Frey - E.Werle Foundation in Berlin, Germany. Together with two other researchers, he developed the “knock-out” technology which allows for shutting down genes in animals to study their function. With this method, which is being used now in research laboratories all over the world, scientists are able to develop animal models of human disease.

Researchers in France and Germany have successfully treated type 1 diabetic mice with a vaccination. The vaccine they designed in this model included structures that the immune system mistakenly attacks in type 1 diabetes.

Potential Target for Specific Therapy - A potential therapeutic target for autoimmune vasculitis has been identified by researchers of the Franz Volhard Clinic for Cardiovascular Diseases (FVK) of the Charité – University Medicine Berlin/HELIOS-Klinikum and the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch.

They isolated the stem cells from a region of the hippocampus, the dentate gyrus, which is an island for neurogenesis in the adult brain. First, they demonstrated that the hippocampus...

When the skin is injured, it first scabs over as a first aid measure, so-to-speak, sealing the wound to keep germs out. Starting from the edge of the wound, keratinocytes...